메뉴 건너뛰기




Volumn 28, Issue 5 PART 1, 2008, Pages 678-681

Nonbloody, red stools from coadministration of cefdinir and iron-supplemented infant formulas

Author keywords

Acute otitis media; Cefdinir; Infant formula; Iron; Red stools

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFDINIR; HEMOGLOBIN; IRON;

EID: 42949155369     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.5.678     Document Type: Article
Times cited : (8)

References (10)
  • 1
    • 42949136099 scopus 로고    scopus 로고
    • Abbott Laboratories. Omnicef (cefdinir) package insert. Abbott Park, IL; 2003
    • Abbott Laboratories. Omnicef (cefdinir) package insert. Abbott Park, IL; 2003.
  • 2
    • 2342524639 scopus 로고    scopus 로고
    • Clinical practice guideline. Diagnosis and management of acute otitis media
    • American Academy of Pediatrics, American Academy of Family Physicians, Subcommitte on Management of Acute Otitis Media
    • American Academy of Pediatrics, American Academy of Family Physicians, Subcommitte on Management of Acute Otitis Media. Clinical practice guideline. Diagnosis and management of acute otitis media. Pediatrics 2004;113:1451-65.
    • (2004) Pediatrics , vol.113 , pp. 1451-1465
  • 3
    • 0035148229 scopus 로고    scopus 로고
    • Compliance issues related to the selection of antibiotic suspensions for children
    • Steele RW, Thomas MP, Begue RE. Compliance issues related to the selection of antibiotic suspensions for children. Pediatr Infect Dis J 2001;20:1-5.
    • (2001) Pediatr Infect Dis J , vol.20 , pp. 1-5
    • Steele, R.W.1    Thomas, M.P.2    Begue, R.E.3
  • 4
    • 34547654302 scopus 로고    scopus 로고
    • Management of acute otitis media by primary care physicians: Trends since the release of the 2004 American Academy of Pediatrics/American Academy of Family Physicians clinical practice guideline
    • Vernachhio L, Vezina RM, Mitchell AA. Management of acute otitis media by primary care physicians: trends since the release of the 2004 American Academy of Pediatrics/American Academy of Family Physicians clinical practice guideline. Pediatrics 2007;120:281-7.
    • (2007) Pediatrics , vol.120 , pp. 281-287
    • Vernachhio, L.1    Vezina, R.M.2    Mitchell, A.A.3
  • 5
    • 0034086520 scopus 로고    scopus 로고
    • Red stools and Omnicef
    • Nelson J. Red stools and Omnicef. J Pediatr 2000;136:853-4.
    • (2000) J Pediatr , vol.136 , pp. 853-854
    • Nelson, J.1
  • 6
    • 42949162701 scopus 로고    scopus 로고
    • Neocate One Plus product information. Available from, Accessed August 6, 2007
    • Nutricia North America. Neocate One Plus product information. Available from http://www.neocate.com/aaa_neocate/720-neocate-one-nutrients. html. Accessed August 6, 2007.
    • America
    • North, N.1
  • 7
    • 42949111729 scopus 로고    scopus 로고
    • Alimentum product information. Available from, Accessed August 6, 2007
    • Ross Product Division/Abbott. Alimentum product information. Available from http://rpdcon40.ross.com/pn/PediatricProducts.NSF/0/ 7d36d292801ca52685256d93006b6241?OpenDocument. Accessed August 6, 2007.
    • Ross Product Division/Abbott
  • 8
    • 42949161712 scopus 로고    scopus 로고
    • Enfamil with Iron product information. Available from, Accessed February 27, 2008
    • Mead Johnson Nutritionals. Enfamil with Iron product information. Available from http://www.meadjohnson.com/app/iwp/HCP/Content2.do?dm=mj&rid= /HCP_Home/Product_lnfonn ation/Product_Descriptions/EnfamilLIPIL. Accessed February 27, 2008.
    • Nutritionals
  • 9
    • 42949162701 scopus 로고    scopus 로고
    • Neocate Infant product information. Available from, Accessed August 6, 2007
    • Nutricia North America. Neocate Infant product information. Available from http://www.neocate.com/aaa_neocate/682-neocate-infant-nutrients. html. Accessed August 6, 2007.
    • America
    • North, N.1
  • 10
    • 0019799332 scopus 로고
    • A method for estimating the probability of adverse drug reactions
    • Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
    • (1981) Clin Pharmacol Ther , vol.30 , pp. 239-245
    • Naranjo, C.A.1    Busto, U.2    Sellers, E.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.